Hubilu Venture Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Hubilu Venture Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	0	0.12	0.23	0.44		1.19	1.58	1.89	2.23	2.2
General and administrative	0.05	0.04	0.03	0	0.32	0.41	0.54	0.11	0.27	0.29
Operating expenses	-0.21	-0.34	-0.49	0.87	0.6	0.53	0.75	1.14	1.11	1.27
Operating income				-0.43	0.25	0.67	0.83	0.74	1.12	0.93
Interest expense						0.67	0.96	0.99	1.21	1.48
Interest income										0
Other non-operating income				-0.15	-0.43	-0.62	-0.97	-1.02	-1.31	-1.48
Income tax							0	0
Net income	-0.21	-0.24	-0.37	-0.58	-0.18	0.04	-0.15	-0.28	-0.19	-0.55
EBITDA				-0.38	0.35	0.79	1.04	0.94	1.34	1.2
EPS, basic	-0.01	-0.01	-0.01	-0.02	0.01	0.00	-0.01	-0.01	-0.01	-0.02
EPS, diluted	-0.01	-0.01	-0.01	-0.02	-0.01	0.00	-0.01	-0.01	-0.01	-0.02
Shares, basic (weighted)	25.5	25.5	25.7	25.9	26.2	26.2	26.2	26.2	26.2	26.2
Shares, diluted (weighted)	25.5	25.5	25.7	25.9	26.2	26.7	26.2	26.2	26.2	26.2

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0	0.01	0	0.15	0.14	0.2	0.09	0.02	0.01	0.05
Receivables								0	0	0.06
Other current assets	0			0.01				0.01		0.01
Total current assets						0.2	0.09	0.04	0.01	0.12
Property, plant and equipment						13.9	17	16.5	20.9	23.4
Total assets	0.01	1.76	3.39	7.55	9.52	14.1	17.1	16.6	20.9	23.5
Accounts payable	0.03					0		0.02	0	0.03
Total current liabilities						2.29	2.56	1.78	2.6	2.56
Total liabilities	0.19	2.17	3.97	8.31	10.4	14.9	18.1	17.7	22.2	25.3
Total debt			2.92	7	9.01	13.6	16.5	15.9	20.5	22.9
Paid-in capital	0.1	0.1	0.3	0.71	0.74	0.78	0.82	0.91	0.99	1.05
Retained earnings	-0.31	-0.54	-0.91	-1.49	-1.7	-1.63	-1.85	-2.12	-2.31	-2.86
Shareholders' equity	-0.18	-0.42	-0.59	-0.76	-0.9	-0.9	-1	-1.18	-1.29	-1.78
Total equity	-0.18	-0.42	-0.59	-0.76	-0.9	-0.9	-1	-1.18	-1.29	-1.78
Total liabilities and equity	0.01	1.76	3.39	7.55	9.52	14.1	17.1	16.6	20.9	23.5
Shares outstanding	25.5	25.5	25.7	26.2	26.2	26.2	26.2	26.2	26.2	26.2

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-0.21	-0.24	-0.37	-0.58	-0.18	0.04	-0.15	-0.28	-0.19	-0.55
Depreciation and amortization		0.05	0.04	0.05	0.1	0.12	0.21	0.2	0.22	0.27
Stock-based compensation	0.01		0.2	0.38
Change in receivables								-0	-0	-0.06
Change in payables	0.03	0	-0.03	0	0	-0.01	-0	0.02	-0.02	0.03
Cash from operations	-0.18	-0.16	-0.12	-0.07	0.05	0.28	0.23	0.11	0.19	0.11
Capital expenditures			-0.02						-0.53	-0.78
Purchases of investments									-0.08
Cash from investing		0.02	-0.03	-0.07	-0.26	-0.49	-0.56		-0.61	-0.78
Cash from financing	0.16	0.15	0.14	0.29	0.2	0.27	0.22	-0.18	0.4	0.71
Net change in cash	-0.02	-0.01	-0.01	0.15	-0	0.06	-0.11	-0.07	-0.01	0.04
Free cash flow			-0.14						-0.34	-0.67
Interest paid					0.45	0.64	0.88	0.91	1.04	1.2
Income taxes paid					0	0	0.06

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.04 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	42.6%	Operating income / revenue.
EBITDA margin	55.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Net margin	-24.0%	Net income / revenue.
FCF margin	-9.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	4.2%	Cash from operations / revenue.
Return on assets (ROA)	-2.4%	Net income / average total assets.
Capex / revenue	13.8%	Capital expenditures / revenue.
D&A / revenue	12.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-1.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	11.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y	-17.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	4.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	29.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-10.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	5.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	27.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-41.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-21.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	15.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	12.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	11.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	19.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.09x	Current assets / current liabilities.
Quick ratio	0.09x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.07x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	109.4%	Total liabilities / total assets.
Interest coverage	0.65x	Operating income / interest expense.
Working capital	-$1.5M	Current assets - current liabilities.
Tangible book value	-$2.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.10x	Revenue / average total assets.
Fixed asset turnover	0.10x	Revenue / average property, plant and equipment.
Receivables turnover	75.3x	Revenue / average receivables.
Days sales outstanding	5 days	365 x average receivables / revenue.
Capex / operating cash flow	331.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.02	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$0.09	Revenue / diluted weighted shares.
FCF per share	-$0.01	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.00	Cash from operations / diluted weighted shares.
Book value per share	-$0.08	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$0.08	Tangible book value / shares outstanding.
Cash per share	$0.00	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$1.1M	Share price x shares outstanding.
Enterprise value	$943.4K	Market cap + total debt - cash - short-term investments.
P/S	0.45x	Market cap / revenue.
P/OCF	10.8x	Market cap / cash from operations, when positive.
EV/Sales	0.40x	Enterprise value / revenue.
EV/EBIT	0.94x	Enterprise value / operating income, when both are positive.
EV/EBITDA	0.73x	Enterprise value / EBITDA, when both are positive.
FCF yield	-21.4%	Free cash flow / market cap.
Earnings yield	-53.4%	Net income / market cap (the inverse of P/E).

What was Hubilu Venture Corp's revenue in fiscal 2025?

Hubilu Venture Corp reported revenue of $2.2M for fiscal 2025, 1.3% lower than the year before.

Was Hubilu Venture Corp profitable in fiscal 2025?

No. It reported a net loss of $551.4K.

How much free cash flow did Hubilu Venture Corp generate in fiscal 2025?

Cash from operations of $110.8K minus capital expenditures of $781.6K left free cash flow of -$670.8K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Hubilu Venture Corp